SciELO - Scientific Electronic Library Online

vol.28 issue1Papel de la oxigenoterapia hiperbárica en el tratamiento de las complicaciones crónicas derivadas del tratamiento con radioterapia en pacientes con cáncer: bases físicas, técnicas y clínicasValor clínico-biológico de la concentración citosólica de ácido hialurónico en adenocarcinomas pulmonares CD44v6 positivos author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Oncología (Barcelona)

Print version ISSN 0378-4835


COBO DOLS, M. et al. Glutamina sérica como factor predictivo de insuficiencia renal en pacientes oncológicos tratados con quimioterapia basada en cisplatino. Oncología (Barc.) [online]. 2005, vol.28, n.1, pp.36-44. ISSN 0378-4835.

PURPOSE: Glutamine is a vehicle transporting non-toxic nitrogen in the blood. High levels of glutamine are present in renal failure. We studied glutamine searching possible predictive factors associated to the development of renal failure secondary to cisplatin. MATERIAL AND METHODS: We studied 34 patients with different tumors treated with cisplatin-based chemotherapy. We determined the serum amino acid three days after each infusion. RESULTS: Glutamine concentration along the chemotherapy cycles was higher in the patients with renal failure. Glutamine level >1000 µM/L determined after cisplatin administration was strongly predictive of developing renal failure. CONCLUSIONS: The elevation of serum glutamine has a significant predictive value of developing renal failure secondary to cisplatin.

Keywords : Glutamine; Renal failure; Cisplatin.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License